Endoscopic biopsy samples of naïve "colitides" patients: Role of basal plasmacytosis

Journal of Crohn's and Colitis

Volumn 8, Issue 11, 2014, Pages 1438-1443

  Villanacci, Vincenzo ^a   Antonelli, Elisabetta ^b   Reboldi, Gianpaolo ^b   Salemme, Marianna ^a   Casella, Giovanni ^c   Bassotti, Gabrio ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c DESIO HOSPITAL   (Italy)

Author keywords

Basal plasmacytosis; Colitides; Crohn's disease; Eosinophils; Ulcerative colitis

Indexed keywords

ARTICLE; ASCENDING COLON; CECUM; CELLULAR DISTRIBUTION; COLITIS; COLLAGENOUS COLITIS; COLON DISEASE; CONTROLLED STUDY; CROHN DISEASE; DESCENDING COLON; DIVERTICULAR COLITIS; ENDOSCOPIC BIOPSY; EOSINOPHIL; EOSINOPHILIC COLITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM; INFECTIOUS COLITIS; ISCHEMIC COLITIS; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; PLASMA CELL; PLASMACYTOSIS; PRIORITY JOURNAL; PROBABILITY; PSEUDOMEMBRANOUS COLITIS; RADIATION COLITIS; RECEIVER OPERATING CHARACTERISTIC; RECTUM; SIGMOID; TRANSVERSE COLON; ULCERATIVE COLITIS; ADULT; AREA UNDER THE CURVE; BIOPSY; COLON; FEMALE; GASTROINTESTINAL ENDOSCOPY; INTESTINE MUCOSA; MALE; MICROSCOPIC COLITIS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AREA UNDER CURVE; BIOPSY; COLITIS, MICROSCOPIC; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; ENDOSCOPY, GASTROINTESTINAL; EOSINOPHILS; FEMALE; HUMANS; ILEUM; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PLASMA CELLS; RECTUM; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84927786258     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.05.003     Document Type: Article

References (32)

1. Walfish A., Sachar D. Phenotype classification in IBD: is there an impact on therapy?. Inflamm Bowel Dis 2007, 13:1573-1575.
2. Gersemann M., Stange E.F., Wehkamp J. From intestinal stem cells to inflammatory bowel diseases. World J Gastroenterol 2011, 17:3198-3203.
3. Jellema P., van Tulder M.W., van der Horst H.E., Florie J., Mulder C.J., van der Windt D.A. Inflammatory bowel disease: a systematic review on the value of diagnostic testing in primary care. Colorectal Dis 2011, 13:239-254.
4. Stange E.F., Travis S.P., Vermeire S., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006, 55(Suppl. 1):i1-i15.
5. Stange E.F., Travis S.P., Vermeire S., et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008, 2:1-23.
6. Yantiss R.K., Odze R.D. Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract. Am J Gastroenterol 2009, 104:774-783.
7. Peyrin-Biroulet L., Ferrante M., Magro F., Campbell S., Franchimont D., Fidder H., Strid H., et al. Results from the 2nd Scientific Workshop of the ECCO. I: impact of mucosal healing on the course of inflammatory bowel disease, J Crohns Colitis 2011, 5:477-483.
8. Vilela E.G., Torres H.O., Martins F.P., Ferrari Mde L., Andrade M.M., Cunha A.S. Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis. World J Gastroenterol 2012, 18:872-881.
9. Haboubi N.Y., Shaath N.M., Safarani M.N., Ghafar F. Improved diagnostic accuracy of inflammatory bowel disease: a clinicopathological collaborative approach. Tech Coloproctol 2004, 8:117-121.
10. Cornaggia M., Leutner M., Mescoli C., et al. Chronic idiopathic inflammatory bowel diseases: the histology report. Dig Liver Dis 2011, 43(Suppl. 4):S293-S303.
11. Baumgart D.C. Endoscopic surveillance in Crohn's disease and ulcerative colitis: who needs what and when?. Dig Dis 2011, 29(Suppl. 1):32-35.
12. Shepherd N.A. Pathological mimics of chronic inflammatory bowel disease. J Clin Pathol 1991, 44:726-733.
13. Yantiss R.K., Odze R.D. Diagnostic difficulties in inflammatory bowel disease pathology. Histopathology 2006, 48:116-132.
14. Rubio C.A., Johansson C., Kock Y. A quantitative method of estimating inflammation in the rectal mucosa. II. Normal limits in symptomatic patients. Scand J Gastroenterol 1982, 17:1077-1781.
15. Rubio C.A., Johansson C., Kock Y. A quantitative method of estimating inflammation in the rectal mucosa. III. Chronic ulcerative colitis. Scand J Gastroenterol 1982, 17:1083-1087.
16. Rubio C.A., Johansson C., Uribe A., Kock Y. A quantitative method of estimating inflammation in the rectal mucosa. IV. Ulcerative colitis in remission. Scand J Gastroenterol 1984, 19:525-530.
17. Seldenrijk C.A., Morson B.C., Meuwissen S.G., Schipper N.W., Lindeman J., Meijer C.J. Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut 1991, 32:1514-1520.
18. Lessells A.M., Beck J.S., Burnett R.A., et al. Observer variability in the histopathological reporting of abnormal rectal biopsy specimens. J Clin Pathol 1994, 47:48-52.
19. Tanaka M., Riddell R.H., Saito H., Soma Y., Hidaka H., Kudo H. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. Scand J Gastroenterol 1999, 34:55-67.
20. Nostrant T., Kumar N.B., Appelman H.D. Histopathology differentiates acute self-limited colitis from ulcerative colitis. Gastroenterology 1987, 92:318-328.
21. Villanacci V., Manenti S., Antonelli E., Chiudinelli M., Giuliano V., Bassotti G. Non-IBD colitides: clinically useful histopathological clues. Rev Esp Enferm Dig 2011, 103:366-372.
22. Schumacher G., Kollberg B., Sandstedt B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation. Scand J Gastroenterol 1994, 29:318-332.
23. Yantiss R.K., Odze R.D. Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease. Am J Gastroenterol 2007, 102:890-904.
24. Hosmer DW, Lemeshow S. Applied Logistic Regression 2000, John Wiley & Sons Ltd., Chichester, England, ISBN: 9780471356325. 2nd ed.
25. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
26. Magro F., Langner C., Driessen A., et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 2013, 7:827-851.
27. Bessissow T., Lemmens B., Ferrante M., et al. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing. Am J Gastroenterol 2012, 107:1684-1692.
28. Dejaco C., Oesterreicher C., Angelberger S., et al. Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis. Endoscopy 2003, 35:1004-1008.
29. Al-Haddad S., Riddell R.H. The role of eosinophils in inflammatory bowel disease. Gut 2005, 54:1674-1675.
30. Chu V.T., Berek C. The establishment of the plasma cell survival niche in the bone marrow. Immunol Rev 2013, 251:177-188.
31. Canavese G., Bassotti G., Astegiano M., et al. Inflammatory bowel disease: a proposal to facilitate the achievement of an unequivocal diagnosis. World J Gastroenterol 2013, 19:426-428.
32. Bressenot A., Geboes K., Vignaud J.M., Guéant J.L., Peyrin-Biroulet L. Microscopic features for initial diagnosis and disease activity evaluation in inflammatory bowel disease. Inflamm Bowel Dis 2013, 19:1745-1752.